生理活性創傷被覆材市場 – 2029年までの世界予測

Report Overview

The global bioactive dressings market is projected to reach USD 5.8 billion by 2029 from USD 3.5 billion in 2024, at a CAGR of 10.5% during the forecast period.

世界の生理活性創傷被覆材市場は、予測期間中のCAGR 10.5%で、2024年の35億米ドルから2029年までに58億米ドルに達すると予測されています。

The rising incidence of chronic wounds and the increasing elderly population are the major drivers boosting the demand for bioactive dressings. Technology advancements in wound dressings and increased awareness of the benefits like faster healing and patient comfort, are driving market growth, with further expansion anticipated due to ongoing innovation.

“Bioactive dressings segment accounted for the highest market share in the bioactive dressings market, by product type, during the forecast period.”

Based on product type, the bioactive dressings market is divided into bioactive dressings and skin substitutes. In 2023, the bioactive dressings segment led the market. The growth of this segment is primarily driven by the increasing prevalence of chronic, surgical, and traumatic wounds; a rising number of burn injuries; technological advancements in bioactive dressings; and increased spending on the treatment of chronic and surgical wounds

“Chronic wound segment accounted for the highest market share in the bioactive dressings market, by application, during the forecast period.”

Based on application, the bioactive dressings market is divided into acute wounds and chronic wounds. In 2023, the chronic wounds segment held the largest market share. The majority share of this segment is attributed to the increasing elderly population and the rising incidence of chronic wounds, including diabetic foot ulcers, pressure ulcers, arterial ulcers and venous leg ulcers, among others.

“Home Care Settings accounted for the highest CAGR during the forecast period.”

Based on end user, the bioactive dressings market is segmented into hospitals and clinics, long-term care facilities, home care settings, and other end users. In 2023, hospitals and clinics held the largest market share. However, home care settings are projected to grow at the highest CAGR during the forecast period, mainly due to their cost-efficiency compared to hospitals, as well as the convenience and comfort they offer.

“The North America segment accounted for the highest market share in the bioactive dressings market, by region, during the forecast period.”

Bioactive dressings market is divided into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), the Middle East & Africa (MEA) and GCC Countries. During the forecast period the North America is expected to witness a larger market share. The expansion of the bioactive dressings market in North America is fueled by the high prevalence of chronic wounds, advancements in bioactive dressing technologies, and increased healthcare spending.     

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Asia- Pacific (31%), Europe (20%), Latin America- (4%) and MEA-(2%), and GCC (1%).

Prominent companies include 3M (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke Health Care AB (Sweden), Convatec Inc. (UK), Paul Hartmann Ag (Germany), Coloplast Corp (Denmark), Integra LifeSciences Corporation (US), Organogenesis Inc.(US), Essity(Sweden), Covalon Technologies(Canada), Mimedx Group, Inc.(US), Sanara Medtech Inc.(US), Medline Industries, LP.(US), Hollister Incorporated(US), Lohmann & Rauscher (L&R) (Germany), DermaRite Industries, LLC (US), BioTissue (US), LifeNet Health (US), Advancis Medical(UK), Human BioSciences (US), AMERX Health Care (US), Gentell (US) and Axio Biosolutions Pvt Ltd (India).

Research Coverage

This research report categorizes the bioactive dressings market by product type, property type, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioactive dressings market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the bioactive dressings market. Competitive analysis of upcoming startups in the bioactive dressings market ecosystem is covered in this report. 

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioactive dressings market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. 

The report provides insights on the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioactive dressings market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioactive dressings market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the bioactive dressings market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bioactive dressings market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like 3M (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke Health Care AB (Sweden), Convatec Inc. (UK), Paul Hartmann Ag (Germany), Coloplast Corp (Denmark), Integra LifeSciences Corporation (US), Organogenesis Inc.(US), Covalon Technologies(Canada), and Mimedx Group, Inc.(US) among others in the bioactive dressings market strategies.

Table of Contents

1            INTRODUCTION            31

1.1         STUDY OBJECTIVES      31

1.2         MARKET DEFINITION   31

1.2.1      INCLUSIONS & EXCLUSIONS     32

1.3         MARKET SCOPE             33

1.3.1      BIOACTIVE DRESSINGS MARKET SEGMENTATION         33

1.3.2      YEARS CONSIDERED     34

1.4         CURRENCY CONSIDERED          34

1.5         STAKEHOLDERS            34

2            RESEARCH METHODOLOGY     35

2.1         RESEARCH DATA           35

2.1.1      SECONDARY DATA       36

2.1.1.1   Key data from secondary sources     36

2.1.2      PRIMARY DATA 37

2.1.2.1   Primary sources   37

2.1.2.2   Key data from primary sources         38

2.1.2.3   Key industry insights          39

2.1.2.4   Breakdown of primary interviews     39

2.2         MARKET SIZE ESTIMATION       40

2.2.1      BOTTOM-UP APPROACH           40

2.2.1.1   Approach 1: Company revenue estimation approach    41

2.2.1.2   Approach 3: Presentations of companies and primary interviews              41

2.2.1.3   Growth forecast   41

2.2.1.4   CAGR projections             42

2.2.2      TOP-DOWN APPROACH             42

2.3         MARKET BREAKDOWN & DATA TRIANGULATION          44

2.4         STUDY ASSUMPTIONS  45

2.4.1      GROWTH RATE ASSUMPTIONS 45

2.4.2      LIMITATIONS   45

2.5         RISK ASSESSMENT         46

3            EXECUTIVE SUMMARY 47

4            PREMIUM INSIGHTS      51

4.1         BIOACTIVE DRESSINGS MARKET OVERVIEW     51

4.2         BIOACTIVE DRESSINGS MARKET SHARE, BY PRODUCT, 2024 VS. 2029              52

4.3         BIOACTIVE DRESSINGS MARKET SHARE, BY TYPE, 2024 VS. 2029              52

4.4         SKIN SUBSTITUTES MARKET SHARE, BY TYPE, 2024 VS. 2029      53

4.5         BIOACTIVE DRESSINGS MARKET SHARE, BY PROPERTY TYPE, 2024 VS. 2029      53

4.6         BIOACTIVE DRESSINGS MARKET SHARE, BY APPLICATION, 2024 VS. 2029      54

4.7         BIOACTIVE DRESSINGS MARKET SHARE FOR CHRONIC WOUNDS,

BY TYPE, 2024 VS. 2029  54

4.8         BIOACTIVE DRESSINGS MARKET SHARE FOR ACUTE WOUNDS, BY TYPE, 2024 VS. 2029        55

4.9         BIOACTIVE DRESSINGS MARKET SHARE, BY END USER, 2024 VS. 2029              55

4.10       BIOACTIVE DRESSINGS MARKET SHARE FOR HOSPITALS & CLINICS,

BY TYPE, 2024 VS. 2029  56

4.11       BIOACTIVE DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           56

5            MARKET OVERVIEW     57

5.1         INTRODUCTION            57

5.2         MARKET DYNAMICS     57

5.2.1      DRIVERS            58

5.2.1.1   Rising prevalence of chronic wounds              58

5.2.1.2   Growing geriatric population           58

5.2.1.3   Increasing number of surgical procedures worldwide   59

5.2.1.4   Increasing incidence of burn injuries              60

5.2.1.5   Advancements in bioactive dressing technology           60

5.2.2      RESTRAINTS     61

5.2.2.1   High costs of bioactive dressing products       61

5.2.2.2   Limited reimbursement policies       61

5.2.3      OPPORTUNITIES           62

5.2.3.1   Growth potential of emerging countries         62

5.2.3.2   New product development 62

5.2.3.3   Strategic collaboration between market players            63

5.2.4      CHALLENGES   64

5.2.4.1   Difficult regulatory approval process             64

5.2.4.2   Lack of awareness and education     64

5.3         PRICING ANALYSIS        65

5.3.1      AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS    65

5.3.2      AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION              66

5.4         PATENT ANALYSIS        67

5.4.1      LIST OF MAJOR PATENTS          68

5.5         VALUE CHAIN ANALYSIS            69

5.6         SUPPLY CHAIN ANALYSIS          70

5.7         ECOSYSTEM ANALYSIS 72

5.7.1      BIOACTIVE DRESSINGS MARKET: ROLE IN ECOSYSTEM 73

5.8         PORTER’S FIVE FORCES ANALYSIS         74

5.8.1      THREAT OF NEW ENTRANTS    75

5.8.2      THREAT OF SUBSTITUTES         75

5.8.3      BARGAINING POWER OF BUYERS           75

5.8.4      BARGAINING POWER OF SUPPLIERS     75

5.8.5      DEGREE OF COMPETITION       75

5.9         KEY STAKEHOLDERS & BUYING CRITERIA          76

5.9.1      KEY STAKEHOLDERS IN BUYING PROCESS         76

5.9.2      BUYING CRITERIA         76

5.10       REGULATORY ANALYSIS            77

5.10.1    REGULATORY LANDSCAPE       77

5.10.1.1 North America     77

5.10.1.1.1            US         77

5.10.1.1.2            Canada  77

5.10.1.2 Europe  78

5.10.1.3 Asia Pacific          78

5.10.1.3.1            China     78

5.10.1.3.2            Japan     78

5.10.1.3.3            India      78

5.10.1.4 Latin America      78

5.10.1.4.1            Brazil     79

5.10.1.4.2            Mexico  79

5.10.1.5 Middle East         79

5.10.1.6 Africa    79

5.10.2    REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 80

5.11       TRADE ANALYSIS          81

5.11.1    TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES       81

5.12       TECHNOLOGY ANALYSIS           83

5.12.1    KEY TECHNOLOGIES    83

5.12.1.1 Kollagen technology          83

5.12.2    COMPLEMENTARY TECHNOLOGIES     83

5.12.2.1 Bioactive microfiber gelling technology          83

5.12.3    ADJACENT TECHNOLOGIES      84

5.12.3.1 Kerecis intact fish skin technology   84

5.13       KEY CONFERENCES & EVENTS, 2024–2025           84

5.14       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86

5.15       INVESTMENT & FUNDING SCENARIO    87

5.16       IMPACT OF AI ON BIOACTIVE DRESSINGS MARKET       87

6            BIOACTIVE DRESSINGS MARKET, BY PRODUCT 89

6.1         INTRODUCTION            90

6.2         BIOACTIVE DRESSINGS 90

6.2.1      COLLAGEN DRESSINGS 93

6.2.1.1   Unique healing properties and biocompatibility to drive growth 93

6.2.2      ALGINATE DRESSINGS 96

6.2.2.1   Excellent absorption capacity to boost demand for alginate dressings       96

6.2.3      CHITOSAN DRESSINGS 99

6.2.3.1   Rising need for effective, natural wound healing options to

support market growth       99

6.2.4      HONEY DRESSINGS       101

6.2.4.1   Effective and natural wound care management to fuel growth    101

6.2.5      OTHER BIOACTIVE DRESSINGS 104

6.3         SKIN SUBSTITUTES       107

6.3.1      HUMAN DONOR TISSUE-DERIVED PRODUCTS 110

6.3.1.1   High efficacy of human donor tissue-derived products to support market demand              110

6.3.2      ACELLULAR ANIMAL-DERIVED PRODUCTS       113

6.3.2.1   Recognition of importance of ECM in wound treatment to boost development of acellular wound care biologics          113

6.3.3      BIOSYNTHETIC PRODUCTS      116

6.3.3.1   Increased bioburden of infected wounds to stimulate market growth        116

7            BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE  119

7.1         INTRODUCTION            120

7.2         NON-ANTIMICROBIAL DRESSINGS        120

7.2.1      COST-EFFECTIVENESS COMPARED TO ANTIMICROBIAL DRESSINGS TO BOOST MARKET      120

7.3         ANTIMICROBIAL DRESSINGS    123

7.3.1      EFFECTIVENESS IN PREVENTING AND MANAGING INFECTIONS TO

DRIVE GROWTH            123

8            BIOACTIVE DRESSINGS MARKET, BY APPLICATION       127

8.1         INTRODUCTION            128

8.2         CHRONIC WOUNDS      128

8.2.1      DIABETIC FOOT ULCERS           131

8.2.1.1   Increasing prevalence of diabetes to drive growth         131

8.2.2      PRESSURE ULCERS        135

8.2.2.1   Growing geriatric population to drive demand for bioactive dressings      135

8.2.3      VENOUS LEG ULCERS   138

8.2.3.1   Rising prevalence of obesity to boost adoption             138

8.2.4      OTHER CHRONIC WOUNDS      141

8.3         ACUTE WOUNDS           143

8.3.1      SURGICAL WOUNDS     146

8.3.1.1   Rising volume of surgical procedures to support market growth 146

8.3.2      TRAUMATIC WOUNDS 149

8.3.2.1   Increasing number of road accidents to drive growth    149

8.3.3      BURNS  152

8.3.3.1   High incidence of burn injuries to propel market growth            152

9            BIOACTIVE DRESSINGS MARKET, BY END USER 156

9.1         INTRODUCTION            157

9.2         HOSPITALS & CLINICS  157

9.2.1      INPATIENT SETTINGS  161

9.2.1.1   Increasing hospital admissions due to HAIs to drive growth       161

9.2.2      OUTPATIENT SETTINGS            164

9.2.2.1   Rising costs of inpatient facilities to drive demand for

outpatient care settings      164

9.3         HOME CARE SETTINGS 167

9.3.1      LOW COSTS AND CONVENIENCE TO DRIVE GROWTH  167

9.4         LONG-TERM CARE FACILITIES 170

9.4.1      GROWTH IN GERIATRIC & VULNERABLE POPULATIONS TO BOOST DEMAND FOR BETTER LONG-TERM CARE         170

9.5         OTHER END USERS        173

10          BIOACTIVE DRESSINGS MARKET, BY REGION    177

10.1       INTRODUCTIONS          178

10.2       NORTH AMERICA          178

10.2.1    US         184

10.2.1.1 Rising prevalence of chronic diseases to drive market   184

10.2.2    CANADA            187

10.2.2.1 Growing awareness about diabetes and its associated complications to fuel market              187

10.3       EUROPE             192

10.3.1    GERMANY         196

10.3.1.1 Rising focus on medical technology clusters to boost market      196

10.3.2    UK         200

10.3.2.1 Increasing prevalence of surgeries to aid growth          200

10.3.3    FRANCE             204

10.3.3.1 Surge in elderly population to propel market  204

10.3.4    ITALY   208

10.3.4.1 Improved life expectancy to support growth   208

10.3.5    SPAIN   211

10.3.5.1 Increasing median age to augment growth     211

10.3.6    REST OF EUROPE           215

10.4       ASIA PACIFIC    218

10.4.1    CHINA  223

10.4.1.1 Growing incidence of diabetic foot ulceration to drive market    223

10.4.2    JAPAN  227

10.4.2.1 Expanding hospital infrastructure to fuel market          227

10.4.3    INDIA   230

10.4.3.1 Booming medical tourism in India to boost market      230

10.4.4    REST OF ASIA PACIFIC  234

10.5       LATIN AMERICA             238

10.5.1    BRAZIL 242

10.5.1.1 Presence of large patient population to stimulate growth           242

10.5.2    MEXICO             245

10.5.2.1 Growing awareness about effective wound care approaches to support growth              245

10.5.3    REST OF LATIN AMERICA          249

10.6       MIDDLE EAST & AFRICA             252

10.6.1    GROWING DEMAND FOR HEALTHCARE FACILITIES TO AID MARKET GROWTH          252

10.7       GCC COUNTRIES           256

10.7.1    FAVORABLE HEALTHCARE INFRASTRUCTURE AND INITIATIVES

TO BOOST MARKET      256

11          COMPETITIVE LANDSCAPE       260

11.1       OVERVIEW        260

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             260

11.2.1    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOACTIVE DRESSINGS MARKET     261

11.3       REVENUE ANALYSIS      263

11.4       MARKET SHARE ANALYSIS         264

11.4.1    RANKING OF KEY MARKET PLAYERS     265

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   266

11.5.1    STARS  266

11.5.2    EMERGING LEADERS    266

11.5.3    PERVASIVE PLAYERS     266

11.5.4    PARTICIPANTS 266

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      268

11.5.5.1 Company footprint            268

11.5.5.2 Product footprint 268

11.5.5.3 Property footprint             268

11.5.5.4 Application footprint         269

11.5.5.5 Region footprint  269

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          269

11.6.1    PROGRESSIVE COMPANIES       269

11.6.2    RESPONSIVE COMPANIES          270

11.6.3    DYNAMIC COMPANIES 270

11.6.4    STARTING BLOCKS       270

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             272

11.7       COMPANY VALUATION & FINANCIAL METRICS 273

11.7.1    FINANCIAL METRICS    273

11.7.2    COMPANY VALUATION 273

11.8       BRAND/PRODUCT COMPARISON          274

11.9       COMPETITIVE SCENARIO          274

11.9.1    PRODUCT LAUNCHES AND APPROVALS            274

11.9.2    DEALS  275

11.9.3    EXPANSIONS    276

11.9.4    OTHER DEVELOPMENTS           276

12          COMPANY PROFILES    277

12.1       KEY PLAYERS   277

12.1.1    SMITH+NEPHEW           277

12.1.1.1 Business overview 277

12.1.1.2 Products offered  278

12.1.1.3 Recent developments         279

12.1.1.3.1            Expansions          279

12.1.1.3.2            Other developments          280

12.1.1.4 MnM view           280

12.1.1.4.1            Key strengths       280

12.1.1.4.2            Strategic choices  280

12.1.1.4.3            Weaknesses and competitive threats 280

12.1.2    ORGANOGENESIS INC. 281

12.1.2.1 Business overview 281

12.1.2.2 Products offered  282

12.1.2.3 Recent developments         283

12.1.2.3.1            Product approvals 283

12.1.2.3.2            Other developments          284

12.1.2.4 MnM view           284

12.1.2.4.1            Key strengths       284

12.1.2.4.2            Strategic choices  284

12.1.2.4.3            Weaknesses and competitive threats 284

12.1.3    MIMEDX GROUP, INC.   285

12.1.3.1 Business overview 285

12.1.3.2 Products offered  286

12.1.3.3 Recent developments         287

12.1.3.3.1            Product launches and approvals       287

12.1.3.3.2            Deals     287

12.1.3.4 MnM view           288

12.1.3.4.1            Key strengths       288

12.1.3.4.2            Strategic choices  288

12.1.3.4.3            Weaknesses and competitive threats 288

12.1.4    3M         289

12.1.4.1 Business overview 289

12.1.4.2 Products offered  290

12.1.4.3 Recent developments         292

12.1.4.3.1            Other developments          292

12.1.4.4 MnM view           292

12.1.4.4.1            Key strengths       292

12.1.4.4.2            Strategic choices  292

12.1.4.4.3            Weaknesses and competitive threats 292

12.1.5    CARDINAL HEALTH      293

12.1.5.1 Business overview 293

12.1.5.2 Products offered  294

12.1.5.3 MnM view           295

12.1.5.3.1            Key strengths       295

12.1.5.3.2            Strategic choices  295

12.1.5.3.3            Weaknesses and competitive threats 296

12.1.6    B. BRAUN SE     297

12.1.6.1 Business overview 297

12.1.6.2 Products offered  299

12.1.7    MÖLNLYCKE AB             300

12.1.7.1 Business overview 300

12.1.7.2 Products offered  301

12.1.8    CONVATEC INC.             302

12.1.8.1 Business overview 302

12.1.8.2 Products offered  303

12.1.8.3 Recent developments         305

12.1.8.3.1            Product approvals 305

12.1.8.3.2            Deals     305

12.1.9    PAUL HARTMANN AG   306

12.1.9.1 Business overview 306

12.1.9.2 Products offered  307

12.1.10  COLOPLAST CORP.       309

12.1.10.1             Business overview 309

12.1.10.2             Products offered  310

12.1.10.3             Recent developments         311

12.1.10.3.1          Deals     311

12.1.11  INTEGRA LIFESCIENCES CORPORATION            312

12.1.11.1             Business overview 312

12.1.11.2             Products offered  313

12.1.11.3             Recent developments         316

12.1.11.3.1          Deals     316

12.1.12  ESSITY AKTIEBOLAG    317

12.1.12.1             Business overview 317

12.1.12.2             Products offered  318

12.1.12.3             Recent developments         319

12.1.12.3.1          Product launches 319

12.1.12.3.2          Deals     319

12.1.13  COVALON TECHNOLOGIES LTD.           320

12.1.13.1             Business overview 320

12.1.13.2             Products offered  321

12.1.13.3             Recent developments         321

12.1.13.3.1          Other developments          321

12.1.14  SANARA MEDTECH       322

12.1.14.1             Business overview 322

12.1.14.2             Products offered  323

12.1.14.3             Recent developments         324

12.1.14.3.1          Product launches 324

12.1.14.3.2          Deals     324

12.2       OTHER PLAYERS           325

12.2.1    MEDLINE INDUSTRIES, INC.      325

12.2.2    HOLLISTER INCORPORATED    326

12.2.3    L&R GROUP      327

12.2.4    DERMARITE INDUSTRIES, LLC  328

12.2.5    BIOTISSUE        329

12.2.6    LIFENET HEALTH          330

12.2.7    ADVANCIS MEDICAL    331

12.2.8    HUMAN BIOSCIENCES  332

12.2.9    AMERX HEALTH CARE  333

12.2.10  GENTELL          334

12.2.11  AXIO BIOSOLUTIONS PVT. LTD.             335

13          APPENDIX         336

13.1       DISCUSSION GUIDE      336

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             340

13.3       CUSTOMIZATION OPTIONS      342

13.4       RELATED REPORTS       342

13.5       AUTHOR DETAILS         343

LIST OF TABLES

TABLE 1             RISK ASSESSMENT ANALYSIS    46

TABLE 2             AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS              61

TABLE 3             BIOACTIVE DRESSINGS MARKET: RECENT PRODUCT LAUNCHES       62

TABLE 4             BIOACTIVE DRESSINGS MARKET: RECENT COLLABORATIONS OF NOTE           63

TABLE 5             AVERAGE SELLING PRICE TREND OF BIOACTIVE DRESSINGS,

BY PRODUCT, 2021–2023            65

TABLE 6             AVERAGE SELLING PRICE OF BIOACTIVE DRESSINGS, BY REGION (2023) 66

TABLE 7             BIOACTIVE DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS          75

TABLE 8             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOACTIVE DRESSINGS FOR END USERS (%)      76

TABLE 9             KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS  77

TABLE 10           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 80

TABLE 11           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 80

TABLE 12           LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 81

TABLE 13           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         81

TABLE 14           IMPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY,

2019–2023 (USD MILLION)          82

TABLE 15           EXPORT DATA FOR WADDING, GAUZE, AND BANDAGES, BY COUNTRY,

2019–2023 (USD MILLION)          82

TABLE 16           BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF CONFERENCES & EVENTS          84

TABLE 17           BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 90

TABLE 18           BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)          91

TABLE 19           BIOACTIVE DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          91

TABLE 20           NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          91

TABLE 21           EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          92

TABLE 22           ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          92

TABLE 23           LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          92

TABLE 24           KEY PRODUCTS IN COLLAGEN DRESSINGS SEGMENT   93

TABLE 25           COLLAGEN DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          94

TABLE 26           NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          94

TABLE 27           EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          95

TABLE 28           ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          95

TABLE 29           LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          95

TABLE 30           KEY PRODUCTS IN ALGINATE DRESSINGS SEGMENT    96

TABLE 31           ALGINATE DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          97

TABLE 32           NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          97

TABLE 33           EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          98

TABLE 34           ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          98

TABLE 35           LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          98

TABLE 36           KEY PRODUCTS IN CHITOSAN DRESSINGS SEGMENT   99

TABLE 37           CHITOSAN DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          99

TABLE 38           NORTH AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          100

TABLE 39           EUROPE: CHITOSAN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          100

TABLE 40           ASIA PACIFIC: CHITOSAN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          100

TABLE 41           LATIN AMERICA: CHITOSAN DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          101

TABLE 42           KEY PRODUCTS IN HONEY DRESSINGS SEGMENT          102

TABLE 43           HONEY DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          102

TABLE 44           NORTH AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          102

TABLE 45           EUROPE: HONEY DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     103

TABLE 46           ASIA PACIFIC: HONEY DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          103

TABLE 47           LATIN AMERICA: HONEY DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          103

TABLE 48           OTHER BIOACTIVE DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)     105

TABLE 49           NORTH AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          105

TABLE 50           EUROPE: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          106

TABLE 51           ASIA PACIFIC: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          106

TABLE 52           LATIN AMERICA: OTHER BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          107

TABLE 53           KEY PRODUCTS IN SKIN SUBSTITUTES SEGMENT          108

TABLE 54           SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          108

TABLE 55           SKIN SUBSTITUTES MARKET, BY REGION, 2022–2029 (USD MILLION)          109

TABLE 56           NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          109

TABLE 57           EUROPE: SKIN SUBSTITUTES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     109

TABLE 58           ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          110

TABLE 59           LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          110

TABLE 60           KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS SEGMENT  111

TABLE 61           HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)          111

TABLE 62           NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            112

TABLE 63           EUROPE: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         112

TABLE 64           ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         112

TABLE 65           LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            113

TABLE 66           KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS SEGMENT         114

TABLE 67           ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY REGION,

2022–2029 (USD MILLION)          114

TABLE 68           NORTH AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            115

TABLE 69           EUROPE: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          115

TABLE 70           ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         115

TABLE 71           LATIN AMERICA: ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         116

TABLE 72           BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION) 116

TABLE 73           NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          117

TABLE 74           EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          117

TABLE 75           ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          117

TABLE 76           LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          118

TABLE 77           BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022–2029 (USD MILLION)     120

TABLE 78           KEY PRODUCTS IN NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET     121

TABLE 79           NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION,

2022–2029 (USD MILLION)          121

TABLE 80           NORTH AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            122

TABLE 81           EUROPE: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 82           ASIA PACIFIC: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 83           LATIN AMERICA: NON-ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            123

TABLE 84           KEY PRODUCTS IN ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET            123

TABLE 85          ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY REGION,

2022–2029 (USD MILLION)          124

TABLE 86           NORTH AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         124

TABLE 87           EUROPE: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 88           ASIA PACIFIC: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         125

TABLE 89           LATIN AMERICA: ANTIMICROBIAL BIOACTIVE DRESSINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         126

TABLE 90           BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 128

TABLE 91           BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          129

TABLE 92           BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY REGION,

2022–2029 (USD MILLION)          129

TABLE 93           NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            129

TABLE 94           EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)       130

TABLE 95           ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 96           LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            131

TABLE 97           TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021      132

TABLE 98           NUMBER OF PATIENTS DEVELOPING NEW CASES OF DIABETIC FOOT ULCERS, 2022–2029 (THOUSAND)         132

TABLE 99          BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY REGION,

2022–2029 (USD MILLION)          133

TABLE 100         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022–2029 (USD MILLION)        133

TABLE 101         EUROPE: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            134

TABLE 102         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            134

TABLE 103         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            135

TABLE 104         BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY REGION,

2022–2029 (USD MILLION)          136

TABLE 105         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 106         EUROPE: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022–2029 (USD MILLION)          137

TABLE 107         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            137

TABLE 108         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            138

TABLE 109         BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS, BY REGION,

2022–2029 (USD MILLION)          139

TABLE 110         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            139

TABLE 111         EUROPE: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            140

TABLE 112         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            140

TABLE 113         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2022–2029 (USD MILLION)            141

TABLE 114         BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY REGION, 2022–2029 (USD MILLION)           141

TABLE 115         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)   142

TABLE 116         EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            142

TABLE 117         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            142

TABLE 118         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)   143

TABLE 119         BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          143

TABLE 120         BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY REGION,

2022–2029 (USD MILLION)          144

TABLE 121         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            144

TABLE 122         EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)       145

TABLE 123         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)       145

TABLE 124         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            146

TABLE 125         BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION,

2022–2029 (USD MILLION)          147

TABLE 126         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            147

TABLE 127         EUROPE: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2022–2029 (USD MILLION)       148

TABLE 128         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            148

TABLE 129         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR SURGICAL WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 130         BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS, BY REGION,

2022–2029 (USD MILLION)          150

TABLE 131         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 132         EUROPE: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            151

TABLE 133         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            151

TABLE 134         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR TRAUMATIC WOUNDS,

BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 135         BIOACTIVE DRESSINGS MARKET FOR BURNS, BY REGION,

2022–2029 (USD MILLION)          153

TABLE 136         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022–2029 (USD MILLION)            153

TABLE 137         EUROPE: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY,

2022–2029 (USD MILLION)          154

TABLE 138         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY,

2022–2029 (USD MILLION)          154

TABLE 139         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2022–2029 (USD MILLION)            155

TABLE 140         BIOACTIVE DRESSINGS MARKET, BY END USER, 2022–2029 (USD MILLION) 157

TABLE 141         TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2022     158

TABLE 142         BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,

2022–2029 (USD MILLION)          159

TABLE 143         BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY REGION,

2022–2029 (USD MILLION)          159

TABLE 144         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            159

TABLE 145         EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            160

TABLE 146         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            160

TABLE 147         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            161

TABLE 148         BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY REGION,

2022–2029 (USD MILLION)          162

TABLE 149         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            162

TABLE 150         EUROPE: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)      163

TABLE 151         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            163

TABLE 152         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR INPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            164

TABLE 153        BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS, BY REGION,

2022–2029 (USD MILLION)          165

TABLE 154         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            165

TABLE 155         EUROPE: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            166

TABLE 156         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            166

TABLE 157         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OUTPATIENT SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            167

TABLE 158         BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS, BY REGION,

2022–2029 (USD MILLION)          168

TABLE 159         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            168

TABLE 160         EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            169

TABLE 161         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            169

TABLE 162         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)            170

TABLE 163         BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2022–2029 (USD MILLION)        171

TABLE 164         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 165         EUROPE: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES,

BY COUNTRY, 2022–2029 (USD MILLION)            172

TABLE 166         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022–2029 (USD MILLION)          172

TABLE 167         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2022–2029 (USD MILLION)          173

TABLE 168         BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)          174

TABLE 169         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)            174

TABLE 170         EUROPE: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             175

TABLE 171         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)            175

TABLE 172         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)            176

TABLE 173         BIOACTIVE DRESSINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          178

TABLE 174         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          180

TABLE 175         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          181

TABLE 176         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          181

TABLE 177         NORTH AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          181

TABLE 178         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          182

TABLE 179         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          182

TABLE 180         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       182

TABLE 181         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)   183

TABLE 182         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          183

TABLE 183         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY TYPE, 2022–2029 (USD MILLION)       183

TABLE 184         US: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 184

TABLE 185         US: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)          185

TABLE 186         US: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          185

TABLE 187         US: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          185

TABLE 188         US: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     186

TABLE 189         US: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          186

TABLE 190         US: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          186

TABLE 191         US: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022–2029 (USD MILLION) 187

TABLE 192         US: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,

2022–2029 (USD MILLION)          187

TABLE 193         DIABETES INCIDENCE IN CANADA, 2023 VS. 2032            188

TABLE 194         CANADA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          189

TABLE 195         CANADA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 189

TABLE 196         CANADA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189

TABLE 197         CANADA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          190

TABLE 198         CANADA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          190

TABLE 199         CANADA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  190

TABLE 200         CANADA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          191

TABLE 201         CANADA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          191

TABLE 202         CANADA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    191

TABLE 203         EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)    192

TABLE 204         PREVALENCE OF DIABETES IN EUROPE, 2021 VS. 2045   193

TABLE 205         EUROPE: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          193

TABLE 206         EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          193

TABLE 207         EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 194

TABLE 208         EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194

TABLE 209         EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          194

TABLE 210         EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          195

TABLE 211         EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  195

TABLE 212         EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          195

TABLE 213         EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          196

TABLE 214         EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    196

TABLE 215         GERMANY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          197

TABLE 216         GERMANY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)     198

TABLE 217         GERMANY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198

TABLE 218         GERMANY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          198

TABLE 219        GERMANY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          199

TABLE 220         GERMANY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  199

TABLE 221         GERMANY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          199

TABLE 222         GERMANY: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          200

TABLE 223         GERMANY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    200

TABLE 224         UK: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 201

TABLE 225         UK: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)          201

TABLE 226         UK: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          202

TABLE 227         UK: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          202

TABLE 228         UK: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     202

TABLE 229         UK: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          203

TABLE 230         UK: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          203

TABLE 231         UK: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022–2029 (USD MILLION) 203

TABLE 232         UK: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE,

2022–2029 (USD MILLION)          204

TABLE 233         FRANCE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          205

TABLE 234         FRANCE: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 205

TABLE 235         FRANCE: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205

TABLE 236        FRANCE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          206

TABLE 237         FRANCE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          206

TABLE 238         FRANCE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  206

TABLE 239         FRANCE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          207

TABLE 240         FRANCE: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          207

TABLE 241         FRANCE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    207

TABLE 242         ITALY: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     208

TABLE 243         ITALY: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 209

TABLE 244         ITALY: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          209

TABLE 245         ITALY: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          209

TABLE 246         ITALY: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          210

TABLE 247         ITALY: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          210

TABLE 248         ITALY: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          210

TABLE 249         ITALY: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022–2029 (USD MILLION)     211

TABLE 250         ITALY: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    211

TABLE 251         SPAIN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     212

TABLE 252         SPAIN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212

TABLE 253         SPAIN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          213

TABLE 254         SPAIN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          213

TABLE 255         SPAIN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          213

TABLE 256         SPAIN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          214

TABLE 257         SPAIN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          214

TABLE 258         SPAIN: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          214

TABLE 259         SPAIN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    215

TABLE 260         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          215

TABLE 261         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          216

TABLE 262         REST OF EUROPE: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          216

TABLE 263         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          216

TABLE 264         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          217

TABLE 265         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       217

TABLE 266         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)   217

TABLE 267         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          218

TABLE 268         REST OF EUROPE: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY TYPE, 2022–2029 (USD MILLION)       218

TABLE 269         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          220

TABLE 270         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          220

TABLE 271         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          220

TABLE 272         ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221

TABLE 273         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          221

TABLE 274         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          221

TABLE 275         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  222

TABLE 276         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  222

TABLE 277         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          222

TABLE 278         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY TYPE, 2022–2029 (USD MILLION)       223

TABLE 279         CHINA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     224

TABLE 280         CHINA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 224

TABLE 281         CHINA: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          224

TABLE 282         CHINA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          225

TABLE 283         CHINA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          225

TABLE 284         CHINA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          225

TABLE 285        CHINA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          226

TABLE 286         CHINA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          226

TABLE 287         CHINA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    226

TABLE 288         JAPAN: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     227

TABLE 289         JAPAN: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 228

TABLE 290         JAPAN: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          228

TABLE 291         JAPAN: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          228

TABLE 292         JAPAN: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          229

TABLE 293         JAPAN: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          229

TABLE 294         JAPAN: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          229

TABLE 295         JAPAN: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          230

TABLE 296         JAPAN: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    230

TABLE 297         INDIA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     231

TABLE 298         INDIA: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 231

TABLE 299         INDIA: SKIN SUBSTITUTES MARKET, TYPE, 2022–2029 (USD MILLION)          232

TABLE 300         INDIA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          232

TABLE 301         INDIA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          232

TABLE 302         INDIA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          233

TABLE 303         INDIA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          233

TABLE 304         INDIA: BIOACTIVE DRESSINGS MARKET, BY END USER, 2022–2029 (USD MILLION)     233

TABLE 305         INDIA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    234

TABLE 306         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          235

TABLE 307         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION),         235

TABLE 308         REST OF ASIA PACIFIC: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          235

TABLE 309         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022–2029 (USD MILLION)      236

TABLE 310         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          236

TABLE 311         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)            236

TABLE 312         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       237

TABLE 313         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          237

TABLE 314         REST OF ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)       237

TABLE 315         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          238

TABLE 316         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          239

TABLE 317         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          239

TABLE 318         LATIN AMERICA: SKIN SUBSTITUTES MARKET, TYPE, 2022–2029 (USD MILLION) 239

TABLE 319         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          240

TABLE 320         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          240

TABLE 321         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       240

TABLE 322         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  241

TABLE 323         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          241

TABLE 324         LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY TYPE, 2022–2029 (USD MILLION)       241

TABLE 325         BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          242

TABLE 326         BRAZIL: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 243

TABLE 327         BRAZIL: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION)          243

TABLE 328         BRAZIL: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          243

TABLE 329         BRAZIL: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          244

TABLE 330         BRAZIL: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          244

TABLE 331         BRAZIL: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          244

TABLE 332         BRAZIL: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          245

TABLE 333         BRAZIL: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    245

TABLE 334         MEXICO: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          246

TABLE 335         MEXICO: BIOACTIVE DRESSINGS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246

TABLE 336         MEXICO: SKIN SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246

TABLE 337        MEXICO: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          247

TABLE 338         MEXICO: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          247

TABLE 339         MEXICO: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)  247

TABLE 340         MEXICO: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE,

2022–2029 (USD MILLION)          248

TABLE 341         MEXICO: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          248

TABLE 342         MEXICO: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)    248

TABLE 343         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          249

TABLE 344         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          249

TABLE 345         REST OF LATIN AMERICA: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          250

TABLE 346         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022–2029 (USD MILLION)      250

TABLE 347         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           250

TABLE 348         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)   251

TABLE 349         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)        251

TABLE 350         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          251

TABLE 351         REST OF LATIN AMERICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)             252

TABLE 352         DIABETES IN MIDDLE EAST & NORTH AFRICA, 2021       253

TABLE 353         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          253

TABLE 354         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          253

TABLE 355         MIDDLE EAST & AFRICA: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          254

TABLE 356         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE, 2022–2029 (USD MILLION)      254

TABLE 357         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          254

TABLE 358         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS, BY TYPE, 2022–2029 (USD MILLION)            255

TABLE 359         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       255

TABLE 360         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          255

TABLE 361         MIDDLE EAST & AFRICA: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)       256

TABLE 362         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          257

TABLE 363         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY TYPE,

2022–2029 (USD MILLION)          257

TABLE 364         GCC COUNTRIES: SKIN SUBSTITUTES MARKET, BY TYPE,

2022–2029 (USD MILLION)          257

TABLE 365         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2022–2029 (USD MILLION)          258

TABLE 366         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          258

TABLE 367         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR CHRONIC WOUNDS,

BY TYPE, 2022–2029 (USD MILLION)       258

TABLE 368         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR ACUTE WOUNDS, BY TYPE, 2022–2029 (USD MILLION)   259

TABLE 369         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET, BY END USER,

2022–2029 (USD MILLION)          259

TABLE 370         GCC COUNTRIES: BIOACTIVE DRESSINGS MARKET FOR HOSPITALS & CLINICS,

BY TYPE, 2022–2029 (USD MILLION)       259

TABLE 371         OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BIOACTIVE DRESSINGS MARKET           261

TABLE 372         BIOACTIVE DRESSINGS MARKET: DEGREE OF COMPETITION              264

TABLE 373         BIOACTIVE DRESSINGS MARKET RANKING, BY KEY PLAYER, 2023      265

TABLE 374         GLOBAL SKIN SUBSTITUTES MARKET RANKING, BY KEY PLAYER, 2023    266

TABLE 375         BIOACTIVE DRESSINGS MARKET: PRODUCT FOOTPRINT              268

TABLE 376         BIOACTIVE DRESSINGS MARKET: PROPERTY FOOTPRINT              268

TABLE 377         BIOACTIVE DRESSINGS MARKET: APPLICATION FOOTPRINT              269

TABLE 378         BIOACTIVE DRESSINGS MARKET: REGION FOOTPRINT 269

TABLE 379         BIOACTIVE DRESSINGS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            272

TABLE 380         BIOACTIVE DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS        272

TABLE 381         BIOACTIVE DRESSINGS MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JULY 2024           274

TABLE 382         BIOACTIVE DRESSINGS MARKET: DEALS, JANUARY 2021–JULY 2024      275

TABLE 383         BIOACTIVE DRESSINGS MARKET: EXPANSIONS, JANUARY 2021–JULY 2024          276

TABLE 384         BIOACTIVE DRESSINGS MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JULY 2024           276

TABLE 385         SMITH+NEPHEW: COMPANY OVERVIEW            277

TABLE 386         SMITH+NEPHEW: PRODUCTS OFFERED             278

TABLE 387         SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–JULY 2024              279

TABLE 388         SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024          280

TABLE 389         ORGANOGENESIS INC.: COMPANY OVERVIEW  281

TABLE 390         ORGANOGENESIS INC.: PRODUCTS OFFERED   282

TABLE 391         ORGANOGENESIS INC.: PRODUCT APPROVALS, JANUARY 2021–JULY 2024 283

TABLE 392         ORGANOGENESIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024 284

TABLE 393         MIMEDX GROUP, INC.: COMPANY OVERVIEW   285

TABLE 394         MIMEDX GROUP, INC.: PRODUCTS OFFERED    286

TABLE 395         MIMEDX GROUP, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JULY 2024           287

TABLE 396         MIMEDX GROUP, INC.: DEALS, JANUARY 2021–JULY 2024              287

TABLE 397         3M: COMPANY OVERVIEW         289

TABLE 398         3M: PRODUCTS OFFERED          290

TABLE 399         3M: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024 292

TABLE 400         CARDINAL HEALTH: COMPANY OVERVIEW       293

TABLE 401         CARDINAL HEALTH: PRODUCTS OFFERED        294

TABLE 402         B. BRAUN SE: COMPANY OVERVIEW      297

TABLE 403         B. BRAUN SE: PRODUCTS OFFERED       299

TABLE 404         MÖLNLYCKE AB: COMPANY OVERVIEW             300

TABLE 405         MÖLNLYCKE AB: PRODUCTS OFFERED 301

TABLE 406         CONVATEC INC.: COMPANY OVERVIEW             302

TABLE 407         CONVATEC INC.: PRODUCTS OFFERED 303

TABLE 408         CONVATEC INC.: PRODUCT APPROVALS, JANUARY 2021–JULY 2024      305

TABLE 409         CONVATEC INC.: DEALS, JANUARY 2021–JULY 2024         305

TABLE 410         PAUL HARTMANN AG: COMPANY OVERVIEW   306

TABLE 411         PAUL HARTMANN AG: PRODUCTS OFFERED    307

TABLE 412         COLOPLAST CORP.: COMPANY OVERVIEW        309

TABLE 413         COLOPLAST CORP.: PRODUCTS OFFERED         310

TABLE 414         COLOPLAST CORP.: DEALS, JANUARY 2021–JULY 2024   311

TABLE 415         INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW        312

TABLE 416         INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED          313

TABLE 417         INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021–JULY 2024 316

TABLE 418         ESSITY AKTIEBOLAG: COMPANY OVERVIEW     317

TABLE 419         ESSITY AKTIEBOLAG: PRODUCTS OFFERED      318

TABLE 420         ESSITY AKTIEBOLAG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024          319

TABLE 421         ESSITY AKTIEBOLAG: DEALS, JANUARY 2021–JULY 2024 319

TABLE 422         COVALON TECHNOLOGIES LTD.: COMPANY OVERVIEW              320

TABLE 423         COVALON TECHNOLOGIES LTD.: PRODUCTS OFFERED              321

TABLE 424         COVALON TECHNOLOGIES LTD.: OTHER DEVELOPMENTS,

JANUARY 2021–JULY 2024           321

TABLE 425         SANARA MEDTECH: COMPANY OVERVIEW        322

TABLE 426         SANARA MEDTECH: PRODUCTS OFFERED         323

TABLE 427         SANARA MEDTECH: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024          324

TABLE 428         SANARA MEDTECH: DEALS, JANUARY 2021–JULY 2024    324

TABLE 429         MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW       325

TABLE 430         HOLLISTER INCORPORATED: COMPANY OVERVIEW     326

TABLE 431         L&R GROUP: COMPANY OVERVIEW       327

TABLE 432         DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW  328

TABLE 433         BIOTISSUE: COMPANY OVERVIEW         329

TABLE 434         LIFENET HEALTH: COMPANY OVERVIEW           330

TABLE 435         ADVANCIS MEDICAL: COMPANY OVERVIEW     331

TABLE 436         HUMAN BIOSCIENCES: COMPANY OVERVIEW   332

TABLE 437         AMERX HEALTH CARE: COMPANY OVERVIEW   333

TABLE 438         GENTELL: COMPANY OVERVIEW           334

TABLE 439         AXIO BIOSOLUTIONS PVT. LTD.: COMPANY OVERVIEW              335

LIST OF FIGURES

FIGURE 1           MARKETS COVERED     33

FIGURE 2           RESEARCH DESIGN METHODOLOGY    35

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND

DEMAND-SIDE PARTICIPANTS 39

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION    40

FIGURE 5           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH       41

FIGURE 6           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   42

FIGURE 7           BIOACTIVE DRESSINGS MARKET: TOP-DOWN APPROACH              43

FIGURE 8           DATA TRIANGULATION METHODOLOGY         44

FIGURE 9           BIOACTIVE DRESSINGS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 47

FIGURE 10         BIOACTIVE DRESSINGS MARKET, BY PROPERTY TYPE,

2024 VS. 2029 (USD MILLION)     48

FIGURE 11         BIOACTIVE DRESSINGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)     48

FIGURE 12         BIOACTIVE DRESSINGS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 49

FIGURE 13         BIOACTIVE DRESSINGS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 50

FIGURE 14         GROWING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET            51

FIGURE 15         SKIN SUBSTITUTES SEGMENT TO DOMINATE MARKET IN 2029              52

FIGURE 16         COLLAGEN DRESSINGS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD       52

FIGURE 17         HUMAN DONOR TISSUE-DERIVED PRODUCTS TO DOMINATE MARKET

DURING FORECAST PERIOD     53

FIGURE 18         NON-ANTIMICROBIAL DRESSINGS SEGMENT TO DOMINATE MARKET

DURING FORECAST PERIOD     53

FIGURE 19         CHRONIC WOUNDS SEGMENT TO DOMINATE MARKET IN 2029              54

FIGURE 20         DIABETIC FOOT ULCERS SEGMENT TO LEAD MARKET IN 2029              54

FIGURE 21         SURGICAL WOUNDS SEGMENT TO LEAD MARKET IN 2029              55

FIGURE 22         HOSPITALS & CLINICS SEGMENT TO DOMINATE MARKET IN 2029      55

FIGURE 23         INPATIENT SETTINGS SEGMENT TO DOMINATE MARKET IN 2029      56

FIGURE 24         ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BIOACTIVE DRESSINGS MARKET DURING FORECAST PERIOD  56

FIGURE 25         BIOACTIVE DRESSINGS MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES    57

FIGURE 26         PATENT ANALYSIS FOR BIOACTIVE DRESSING PRODUCTS

(JANUARY 2014–DECEMBER 2023)           67

FIGURE 27         BIOACTIVE DRESSINGS MARKET: VALUE CHAIN ANALYSIS              70

FIGURE 28         BIOACTIVE DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS              71

FIGURE 29         BIOACTIVE DRESSINGS MARKET: ECOSYSTEM ANALYSIS              72

FIGURE 30         BIOACTIVE DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS          74

FIGURE 31         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF

BIOACTIVE DRESSINGS FOR END USERS             76

FIGURE 32         KEY BUYING CRITERIA OF BIOACTIVE DRESSINGS FOR END USERS  76

FIGURE 33         REVENUE SHIFT IN BIOACTIVE DRESSINGS MARKET     86

FIGURE 34         NORTH AMERICA: BIOACTIVE DRESSINGS MARKET SNAPSHOT        180

FIGURE 35         ASIA PACIFIC: BIOACTIVE DRESSINGS MARKET SNAPSHOT              219

FIGURE 36         REVENUE ANALYSIS OF KEY PLAYERS IN BIOACTIVE

DRESSINGS MARKET (2021–2023)            263

FIGURE 37         MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOACTIVE

DRESSINGS MARKET (2023)       264

FIGURE 38         BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023     267

FIGURE 39         BIOACTIVE DRESSINGS MARKET: COMPANY FOOTPRINT              268

FIGURE 40         BIOACTIVE DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023           271

FIGURE 41         EV/EBITDA OF KEY VENDORS   273

FIGURE 42         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS             273

FIGURE 43         BIOACTIVE DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS          274

FIGURE 44         SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 278

FIGURE 45         ORGANOGENESIS INC.: COMPANY SNAPSHOT (2023)    282

FIGURE 46         MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2023)     285

FIGURE 47         3M: COMPANY SNAPSHOT (2023)           290

FIGURE 48         CARDINAL HEALTH: COMPANY SNAPSHOT (2023)         294

FIGURE 49         B. BRAUN SE: COMPANY SNAPSHOT (2023)        298

FIGURE 50         MÖLNLYCKE AB: COMPANY SNAPSHOT (2023) 301

FIGURE 51         CONVATEC INC.: COMPANY SNAPSHOT (2023) 303

FIGURE 52         PAUL HARTMANN AG: COMPANY SNAPSHOT (2023)      307

FIGURE 53         COLOPLAST CORP.: COMPANY SNAPSHOT (2023)          310

FIGURE 54         INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)          313

FIGURE 55         ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2023)       318

FIGURE 56         COVALON TECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)              320

FIGURE 57         SANARA MEDTECH: COMPANY SNAPSHOT (2023)          322

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧